HCA Healthcare Inc. ($HCA) Stock Forecast: Down 5.7% Today

What is HCA Healthcare Inc.?

HCA Healthcare (HCA) is a leading healthcare provider with a significant presence in the industry. The company offers a wide range of medical services and operates numerous hospitals and healthcare facilities across the United States.

Why is HCA Healthcare Inc. going down?

HCA stock is down 5.7% on May 19, 2026 13:42

• The significant reduction in stake by Maj Invest Holding A S and the adjusted price target by JPMorgan to $490 from $535, with a maintained "Neutral" rating, likely contributed to the bearish movement in HCA's stock.
• Despite HCA Healthcare reporting mixed Q4 results, with revenue exceeding expectations but EPS slightly missing estimates, the market sentiment might have been influenced by the lowered price target and neutral outlook by JPMorgan.
• The increase in stake by Handelsbanken Fonder AB and the optimistic FY2026 EPS guidance provided by HCA Healthcare could not offset the impact of the reduced stake and revised price target, leading to the bearish market movement observed today.

HCA Price Chart

HCA Technical Analysis

HCA News

Inside HCA staffers' 350,000 volunteer hours helping nonprofits

HCA Healthcare announced the results of its seventh annual "We Show Up for Our Communities" volunteer initiative. Colleagues across the country volunteered over 41,800 hours to support 1,866 nonprofits through initiatives like packing snack bags for students. In 2025, HCA Healthcare colleagues accumulated over 350,000 volunteer hours and supported over 10,000 charitable organizations nationwide.

https://www.stocktitan.net/news/HCA/hca-healthcare-colleagues-volunteer-more-than-41-800-hours-during-7w55scdoktng.html

HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative

HCA Healthcare announced that its colleagues volunteered over 41,800 hours during its seventh annual "We Show Up for Our Communities" initiative, supporting 1,866 nonprofits nationwide. This effort involved 9,790 volunteers, with significant participation in Nashville where nearly 3,000 colleagues contributed almost 13,500 hours. The company also highlighted its broader commitment, with over 350,000 volunteer hours and $8.3 million in grants awarded in 2025.

https://www.businesswire.com/news/home/20260519385365/en/HCA-Healthcare-Colleagues-Volunteer-More-Than-41800-Hours-During-Annual-Days-of-Service-Initiative

HCA Healthcare, Inc. $HCA Shares Sold by Maj Invest Holding A S

Maj Invest Holding A S significantly reduced its stake in HCA Healthcare by 48.4% in the fourth quarter, selling 163,916 shares and retaining 174,594 shares valued at $81.5 million. HCA Healthcare reported mixed Q4 results, with EPS slightly missing estimates at $7.15 but revenue exceeding expectations at $19.11 billion, a 4.3% year-over-year increase. The company also declared a quarterly dividend of $0.78 per share, which annualizes to a 0.7% yield.

https://www.marketbeat.com/instant-alerts/filing-hca-healthcare-inc-hca-shares-sold-by-maj-invest-holding-a-s-2026-05-19/

JPMorgan Adjusts Price Target on HCA Healthcare to $490 From $535, Maintains Neutral Rating

JPMorgan has revised its price target for HCA Healthcare (NYSE: HCA) to $490, down from the previous $535, while keeping a "Neutral" rating on the stock. This adjustment reflects a moderated outlook for the healthcare provider. The article also mentions other recent analyst target adjustments for HCA Healthcare from firms like Argus, Deutsche Bank, Bernstein, Oppenheimer, and Truist, indicating a general trend of re-evaluating the company's valuation.

https://www.marketscreener.com/news/jpmorgan-adjusts-price-target-on-hca-healthcare-to-490-from-535-maintains-neutral-rating-ce7f5adbdd8ef226

Handelsbanken Fonder AB Boosts Position in HCA Healthcare, Inc. $HCA

Handelsbanken Fonder AB increased its stake in HCA Healthcare, Inc. by 7.9% in the fourth quarter, bringing its total holdings to 213,272 shares valued at approximately $99.6 million. Institutional investors collectively own 62.73% of HCA's stock. Despite missing consensus EPS estimates slightly, HCA Healthcare reported a revenue beat and provided optimistic FY2026 EPS guidance, while analysts maintain a "Moderate Buy" rating with an average target price of $517.82.

https://www.marketbeat.com/instant-alerts/filing-handelsbanken-fonder-ab-boosts-position-in-hca-healthcare-inc-hca-2026-05-19/

Trending Today

HCA Healthcare Inc. Price History

11.01.2026 - HCA Stock was up 5.0%

• The reduction in stake by Prospera Financial Services Inc. did not deter other institutional investors like Norges Bank and Viking Global Investors LP from increasing their positions in HCA, indicating confidence in the company's growth prospects.
• HCA's robust financial performance, beating EPS estimates, issuing optimistic guidance, and raising its dividend, likely contributed to the bullish movement in its stock price.
• The upcoming community meetings regarding HCA Mission Health System may have also generated positive sentiment among investors, showcasing transparency and accountability in the company's operations.
• HCA's strategic focus on expanding market presence, enhancing digital capabilities, and managing risks highlighted in its SEC 10-K report further solidifies investor confidence in the company's long-term sustainability and growth potential.

11.04.2026 - HCA Stock was down 1.6%

• Despite boosted Q2 EPS estimates, HCA Healthcare experienced a bearish movement, possibly due to profit-taking after recent price increases.
• The increase in institutional investors acquiring more shares could have initially driven positive sentiment, but the subsequent trimming of stakes by another investor might have raised concerns among investors.
• The strong first-quarter results and dividend hike reported by HCA Healthcare could have initially driven investor interest, but the overall mixed quarterly performance may have led to profit realization and contributed to the bearish movement.
• The market's reaction suggests that while the company's fundamentals remain strong, investors may be cautious about the stock's short-term outlook, leading to the bearish movement today.

24.03.2026 - HCA Stock was down 8.2%

• HCA Healthcare saw a decline in its stock price despite posting strong first-quarter financial results.
• Factors contributing to the stock's drop include weak volume trends, specifically lower admissions and emergency room visits related to respiratory issues.
• Concerns about the company's valuation arose following mixed Q1 results – a miss in diluted EPS estimates but a beat in revenue expectations.
• Investor sentiment may have been influenced by the company's leverage and insider selling, as per observations by GuruFocus.

24.03.2026 - HCA Stock was down 9.1%

• Despite reporting a 4.3% increase in revenues and a 10.9% rise in diluted EPS, HCA Healthcare's stock took a hit due to lower respiratory-related admissions and the impact of a winter storm on patient volumes.
• The company's reaffirmation of its 2026 guidance, including expectations of 2-3% volume growth for the remainder of the year, was not enough to offset concerns about the softer respiratory season and dynamic environment.
• Investors may have reacted negatively to the mixed same-facility volume trends and the ongoing challenges related to health insurance exchanges and Medicaid conversions, leading to the bearish movement in HCA's stock price today.

24.03.2026 - HCA Stock was down 9.9%

• Despite reporting first-quarter results that slightly beat analyst expectations, HCA Healthcare experienced a significant bearish movement, dropping nearly 8%.
• The stock's decline can be attributed to weak volume trends, including a notable decrease in respiratory-related admissions and emergency room visits, as well as the absence of typical seasonal increases.
• Concerns about the company being overvalued, highlighted by GuruFocus, with a GF Value of $431.18 versus the current price of $474.03, might have also contributed to the bearish sentiment.
• The market's reaction could also be influenced by the mixed Q1 2026 results, with diluted EPS missing estimates but revenue beating expectations, leading to uncertainty among investors about the company's future performance.

17.02.2026 - HCA Stock was down 5.2%

• An increase in holdings by Mercer Global Advisors Inc. ADV in HCA Healthcare could reflect confidence in the company's future prospects, although market sentiment may have been influenced by various factors.
• Despite HCA Healthcare's strong performance and strategic investments, notable insider selling activities in the healthcare sector, involving CEOs and Directors of companies like ResMed Inc. and Tenet Healthcare Corporation, might have had a negative impact on investor sentiment.
• Analysts supporting a "Moderate Buy" rating for HCA Healthcare amidst insider selling and institutional adjustments present a mixed outlook, potentially contributing to the stock's bearish movement.
• HCA Healthcare's emphasis on AI-driven efficiencies and disciplined capital deployment for future growth, highlighted in industry conferences, contrasts with insider selling trends in the sector, complicating market dynamics and potentially affecting the stock price adversely.

27.00.2026 - HCA Stock was up 7.1%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst expectations and resulting in a bullish movement in the stock.
• Investor confidence was further boosted by the company's announcement of a new $10 billion share repurchase program and an increased quarterly dividend.
• Despite a cautious revenue guidance for 2026, HCA Healthcare's commitment to profitability and continued EPS growth highlighted its ability to effectively navigate a stable operating environment.
• The positive market sentiment towards HCA Healthcare was evident through increased institutional investments, with entities like Markel Group Inc. acquiring additional shares, indicating a growing confidence in the company's performance and future prospects.

28.00.2026 - HCA Stock was down 5.3%

• Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
• The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
• The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
• The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

11.01.2026 - HCA Stock was up 6.6%

• Unusual options activity on HCA Healthcare, with predominantly bullish trades and a price window of $350.0 to $560.0, signals a positive sentiment among investors, propelling the stock price higher.
• The reduction in stake by Prospera Financial Services Inc. may have initially raised concerns, but increased positions by other institutional investors and robust quarterly earnings report surpassing EPS estimates and raising dividends have reassured investors and fueled the bullish trend.
• The upcoming community meetings to discuss updates on HCA Mission Health System could be viewed as a favorable move towards transparency and accountability, potentially enhancing investor confidence in HCA Healthcare's operations and future outlook.

19.04.2026 - HCA Stock was down 5.7%

• The significant reduction in stake by Maj Invest Holding A S and the adjusted price target by JPMorgan to $490 from $535, with a maintained "Neutral" rating, likely contributed to the bearish movement in HCA's stock.
• Despite HCA Healthcare reporting mixed Q4 results, with revenue exceeding expectations but EPS slightly missing estimates, the market sentiment might have been influenced by the lowered price target and neutral outlook by JPMorgan.
• The increase in stake by Handelsbanken Fonder AB and the optimistic FY2026 EPS guidance provided by HCA Healthcare could not offset the impact of the reduced stake and revised price target, leading to the bearish market movement observed today.

12.01.2026 - HCA Stock was up 5.7%

• A notable reduction in LSV Asset Management's stake in HCA Healthcare by 2.9% initially raised concerns but did not dampen market sentiment due to the company's robust financial performance.
• The increase in earnings estimates for HCA Healthcare by Zacks Research, along with a "Hold" rating, indicates rising confidence in the company's future prospects, contributing to the positive market movement.
• HCA's stock hitting a new 52-week high and receiving an "Outperform" rating from analysts reflects investors' optimism about its ongoing growth and profitability.
• Despite a slight decrease in the Q1 2026 EPS estimate and an insider share sale causing some negative sentiment, the overall positive news of strong earnings, dividend increase, and strategic expansion into outpatient services drove HCA's stock to new highs.

12.02.2026 - HCA Stock was up 2.7%

• HCA Healthcare is a leading healthcare services provider in the US, offering a wide range of medical services to patients.
• The overall market sentiment for HCA Healthcare has been positive, with strong bullish movement today.
• Franklin Resources Inc. reducing its stake in HCA Healthcare did not hinder the company's performance, as it surpassed quarterly EPS expectations, raised its dividend, and received a "Moderate Buy" rating from analysts, leading to increased investor confidence.
• First Trust Advisors LP increasing its shares in HCA Healthcare suggests growing institutional interest, which has further bolstered market sentiment.
• The optimistic prospects for HCA Healthcare, coupled with the rise in quarterly dividend, likely contributed to the surge in the stock price today.